1987
DOI: 10.2337/diacare.10.1.33
|View full text |Cite
|
Sign up to set email alerts
|

Residual β-Cell Function in Children With IDDM: Reproducibility of Testing and Factors Influencing Insulin Secretory Reserve

Abstract: Reproducibility of C-peptide secretion was assessed in 20 children (group 1) by their responses to two Sustacal- (a mixed liquid meal) stimulation tests performed 7-14 days apart. For the 12 C-peptide-positive children (basal C-peptide greater than or equal to 0.03 pmol/ml) there were no differences in the basal or stimulated values between tests 1 and 2. The effect of exogenous insulin on C-peptide secretion was assessed in 20 other children (group 2) by their responses to two Sustacal tests, one test without… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
22
0

Year Published

1987
1987
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(26 citation statements)
references
References 21 publications
4
22
0
Order By: Relevance
“…Serum C-peptide response to glucagon in patients treated with sulfonylurea or insulin in the present study was substantially the same as the reported values (Matsuda et al, 1985) and it was suggested that the residual B cell function was not lowered in long-standing NIDDM, being consistent with previous studies (Lev-Ran et al, 1986;Snehalatha et al, 1986). Some reports on IDDM indicated that the more active the residual B cell function, the better the metabolic control (Gonen et al, 1979;Clarson et al, 1987;Sjoberg et al, 1987). The present study on NIDDM, however, differed from them in that the residual B cell function did not significantly correlate with the glycemic levels at the first visit, through the observation period and at present.…”
Section: Discussionsupporting
confidence: 91%
“…Serum C-peptide response to glucagon in patients treated with sulfonylurea or insulin in the present study was substantially the same as the reported values (Matsuda et al, 1985) and it was suggested that the residual B cell function was not lowered in long-standing NIDDM, being consistent with previous studies (Lev-Ran et al, 1986;Snehalatha et al, 1986). Some reports on IDDM indicated that the more active the residual B cell function, the better the metabolic control (Gonen et al, 1979;Clarson et al, 1987;Sjoberg et al, 1987). The present study on NIDDM, however, differed from them in that the residual B cell function did not significantly correlate with the glycemic levels at the first visit, through the observation period and at present.…”
Section: Discussionsupporting
confidence: 91%
“…However, they reported different basal values which can respond to stimulation. Such values were 0.09 (Clarson et al, 1987), 0.18 (Eff et al, 1989 and 0.39 ng/ml (Faber & Binder, 1977). The variation in these levels was probably due to the different ages and different diabetes duration of the studied populations (Pozzan et al, 1997).…”
Section: Discussionmentioning
confidence: 76%
“…To reproduce as much as possible the usual condition of the patients, we decided to maintain their usual insulin dose before the test meal. One study (2) reported no difference in C-peptide response to Sustacal ® , with and without the use of exogenous insulin. In that study, as in the present report, no patient developed hypoglycemia during the test.…”
Section: R Pozzan Et Almentioning
confidence: 99%
“…The determination of C-peptide is a widely used method to evaluate residual insulin secretion in type 1 diabetic patients using exogenous insulin (1)(2)(3)(4)(5). However, comparison between the studies is impaired by the variety of methods of stimulation used and time of sampling.…”
Section: Introductionmentioning
confidence: 99%